2. Braunwald E. Cardiomyopathies: an overview. Circ Res. 2017; 121: 711-21. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.117.311812.
3. Sisakian H. Cardiomyopathies: evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014; 6(6): 478-94. http://www.wjg-net.com/1949-8462/full/v6/i6/478.htm.
4. Porcari A, Angelis GD, Romani S, Paldino A, Artico J, Cannata A, et al. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. Expert Rev Cardiovasc Ther. 2019; 17(1): 53-63. https://www.ncbi.nlm.nih.gov/pubmed/30457393.
8. Schultheiss HP, Fairweather D, Caforio ALP, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019 May 9;5(1):32. doi: 10.1038/s41572-019-0084-1.
9. Brown KN, Pendela VS, Ahmed I, et al. Restrictive Cardiomyopathy. StatPearls Publishing. 2022 https://www.ncbi.nlm.nih.gov/books/NBK537234/
10. Saini H, Tabtabai S, Stone JR, Ellinor PT. Pathophysiology of Cardiomyopathies. Cellular and Molecular Pathobiology of Cardiovascular Disease. Massachusetts; Elsevier: 2014. Chapter 6; p.101–119. https://www.sciencedirect.com/science/article/pii/B9780124052062000065.
11. Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci. 2021 Jul 19;22(14):7722. doi: 10.3390/ijms22147722.
12. Basit H, Brito D, Sharma S. Hypertrophic Cardiomyopathy. StatPearls Publishing. 2022. https://www.ncbi.nlm.nih.gov/books/NBK430788/
13. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937.
14. Khalid N, Ahmad SA, Shlofmitz E, et al. Pathophysiology of Takotsubo Syndrome. StatPearls Publishing. 2022. https://www.ncbi.nlm.nih.gov/books/NBK538160/
15. Ahmad SA, Brito D, Khalid N, et al. Takotsubo Cardiomyopathy. StatPearls Publishing. 2022 https://www.ncbi.nlm.nih.gov/books/NBK430798/
16. Huggins GS, Kinnamon DD, Haas GJ, et al; DCM Precision Medicine Study of the DCM Consortium. Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy. JAMA. 2022 Feb 1;327(5):454-463. doi: 10.1001/jama.2021.24674.